![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Medtronic Combines Vascular, Cardiac Surgery Businesses
Medtronic Combines Vascular, Cardiac Surgery Businesses
Medtronic announced the formation of Medtronic CardioVascular, a new global business combining the firm's vascular and cardiac surgery businesses.
Medtronic CardioVascular will have combined revenues of approximately $1.9 billion, the company said, and will consist of four major product divisions:
Coronary and peripheral -- minimally invasive catheter and stent-based technologies for the treatment of atherosclerosis;
Endovascular innovations -- stent grafts for the treatment of aortic abdominal and thoracic aneurysms;
Structural heart disease -- products for the treatment of heart valve disease and atrial fibrillation; and
Revascularization and surgical therapies -- open heart and coronary bypass grafting surgical products.
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
18Jul
-
21Oct